Globus Medical, Inc. (GMED)
87.42
+0.32
(+0.37%)
USD |
NYSE |
Nov 05, 09:34
Globus Medical Net Income (Quarterly) : 151.57M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 151.57M |
| March 31, 2026 | 124.30M |
| December 31, 2025 | 140.59M |
| September 30, 2025 | 118.97M |
| June 30, 2025 | 202.85M |
| March 31, 2025 | 75.46M |
| December 31, 2024 | 26.50M |
| September 30, 2024 | 51.84M |
| June 30, 2024 | 31.76M |
| March 31, 2024 | -7.117M |
| December 31, 2023 | 15.04M |
| September 30, 2023 | 0.998M |
| June 30, 2023 | 57.71M |
| March 31, 2023 | 49.13M |
| December 31, 2022 | 50.06M |
| September 30, 2022 | 47.43M |
| June 30, 2022 | 54.59M |
| March 31, 2022 | 38.08M |
| December 31, 2021 | 15.11M |
| September 30, 2021 | 47.21M |
| June 30, 2021 | 41.54M |
| March 31, 2021 | 45.33M |
| December 31, 2020 | 52.96M |
| September 30, 2020 | 44.22M |
| June 30, 2020 | -20.84M |
| Date | Value |
|---|---|
| March 31, 2020 | 25.95M |
| December 31, 2019 | 45.53M |
| September 30, 2019 | 38.31M |
| June 30, 2019 | 38.16M |
| March 31, 2019 | 33.21M |
| December 31, 2018 | 36.75M |
| September 30, 2018 | 35.21M |
| June 30, 2018 | 44.98M |
| March 31, 2018 | 39.54M |
| December 31, 2017 | 24.38M |
| September 30, 2017 | 25.59M |
| June 30, 2017 | 28.67M |
| March 31, 2017 | 28.71M |
| December 31, 2016 | 24.30M |
| September 30, 2016 | 26.23M |
| June 30, 2016 | 25.81M |
| March 31, 2016 | 28.01M |
| December 31, 2015 | 37.60M |
| September 30, 2015 | 26.48M |
| June 30, 2015 | 24.05M |
| March 31, 2015 | 24.65M |
| December 31, 2014 | 27.64M |
| September 30, 2014 | 23.06M |
| June 30, 2014 | 20.65M |
| March 31, 2014 | 21.14M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Abbott Laboratories | 920.00M |
| Merit Medical Systems, Inc. | 42.31M |
| Teleflex, Inc. | 41.76M |
| Glaukos Corp. | 2.018M |
| The Cooper Cos., Inc. | 432.80M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 789.61M |
| Total Expenses (Quarterly) | 638.04M |
| EPS Diluted (Quarterly) | 1.103 |
| Enterprise Value | 11.21B |
| Gross Profit Margin (Quarterly) | 65.92% |
| Profit Margin (Quarterly) | 19.20% |
| Earnings Yield | 4.47% |
| Operating Earnings Yield | 5.66% |
| Normalized Earnings Yield | 4.679 |